Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2014-2024

Pharma Leader Series: Top 25 OphthalmicPharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2014-2024 PR Newswire LONDON, January 27, 2014 New study shows you commercial prospects for leading eye drug producers What does the future hold for top companies in the pharma ophthalmics industry? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our 235 page report provides 152 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. We analyse the 38 leading companies for eye medicines, to help you see the future of that industry and market. You will see financial results, interviews, trends, opportunities, and revenue predictions. Forecasts from 2014-2024 and other analyses show you commercial prospects Besides revenue forecasting to 2024, our new study provides you with recent results, growth rates, and market shares. There you find original analyses, with business outlooks and developments. Discover qualitative analyses (including SWOT and Porter's Five Forces Analysis), company profiles and commercial developments. Read the full transcripts of five exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales: - Professor David T.